Children’s Nutrition Research Center Staff Publications

Publication Date

2-7-2026

Journal

The Journal of Clinical Endocrinology and Metabolism

DOI

10.1210/clinem/dgag055

PMID

41655235

PMCID

PMC13007975

PubMedCentral® Posted Date

3-24-2026

PubMedCentral® Full Text Version

Author MSS

Abstract

Context: Arginine (Arg) is an important amino acid in T2D as a potent insulin secretagogue and precursor for nitric oxide (NO). Citrulline (Cit), the substrate for de novo Arg synthesis, is mostly produced from glutamine (Gln).

Objective: We aimed to investigate their metabolism in T2D using novel stable isotope tracer approach.

Methods: We studied 42 individuals (21 with T2D, 21 controls). After overnight fasting, blood samples were collected following pulse administration of stable amino acid tracers. Plasma concentrations and isotopic enrichments were measured by LC-MS/MS, and compartmental analyses were performed to calculate their whole-body production (WBP) rates and kinetics.

Results: The cohort was 59.5% female, with a mean age of 64.4 (7.5) years and a BMI of 33.0 (4.3) kg/m2 (all p>0.05). After adjusting for sex and age, the T2D group had lower plasma concentrations of Arg (p=0.007), Cit (p=0.002), and Gln (p=0.002) than the control group. In T2D, WBP was lower for Cit (p=0.004) but higher for Gln (p=0.037) and glutamate (p=0.017) after controlling for age, sex and lean soft tissue mass. The T2D group also had lower Cit intracellular production, but higher Gln clearance and intracellular pool size, and a trend towards higher Arg clearance.

Conclusion: Significant dysregulation exists in Arg-Cit-Gln metabolism in T2D. Our findings suggest a working model in which increased Gln turnover stimulates gluconeogenesis, increases Gln consumption, and reduces Cit availability for Arg and NO synthesis, thereby contributing to metabolic dysregulation in T2D. Interventions targeting Gln-driven gluconeogenesis while increasing Cit availability may benefit T2D management.

Keywords

type 2 diabetes, arginine, citrulline, stable tracer, whole-body production rate

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.